Abstract

This study investigated the surgical outcomes of Coats disease and the role of external drainage (XD) of subretinal fluid (SRF). The study is a multicenter retrospective interventional case series of 26 consecutive eyes of 26 patients who underwent surgeries for advanced Coats disease with retinal detachment. Main outcomes measured were: 1) comparison of complete SRF resolution with or without XD, and 2) variables that were associated with functional postoperative best-corrected visual acuity (BCVA) defined as BCVA of 0.1 or better, 3) intraocular vascular endothelial growth factor (VEGF) levels. Complete SRF resolution was achieved in all 14 eyes in which XD had been performed and in 75% of 12 eyes in which XD had not been performed (P = .03). Multivariable logistic regression analysis revealed that initial BCVA was the only variable associated with functional postoperative BCVA (odds ratio 3.24, 95% CI 0.93–11.33; P = .04). Markedly elevated VEGF levels were noted in the SRF compared with those in the vitreous humor (49,760 ± 52,990 vs. 707 ± 611 pg/mL, P = .03). XD seems to provide better anatomical success than without XD in the treatment of advanced Coats disease as XD could effectively eliminate substantial amount of VEGF in the SRF.

Highlights

  • This study investigated the surgical outcomes of Coats disease and the role of external drainage (XD) of subretinal fluid (SRF)

  • As intraocular vascular endothelial growth factor (VEGF) concentration is significantly increased in Coats d­ isease[5,6], anti-VEGF therapy a­ lone[7,8], intravitreal steroid i­mplant[9] or in combination with ablative ­therapy[10,11,12] has been successful in reducing subretinal fluid (SRF)

  • Complete SRF resolution was achieved in all cases in which SRF was drained externally, whereas only 75% of cases achieved complete SRF resolution with PPV alone

Read more

Summary

Introduction

This study investigated the surgical outcomes of Coats disease and the role of external drainage (XD) of subretinal fluid (SRF). Main outcomes measured were: 1) comparison of complete SRF resolution with or without XD, and 2) variables that were associated with functional postoperative best-corrected visual acuity (BCVA) defined as BCVA of 0.1 or better, 3) intraocular vascular endothelial growth factor (VEGF) levels. In some advanced Coats disease cases (stage 3 or higher), even multiple sessions of ablative and anti-VEGF therapy often fail to achieve SRF reduction or prevent disease progression. In these cases, surgical intervention may be required to reattach the ­retina[13]. We reviewed our surgical results and investigated VEGF concentrations of aqueous, vitreous, and subretinal fluid in some eyes

Objectives
Methods
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.